OPTN (OptiNose Inc) Net Profit

Corporate emblem and logo of optinose.com (OPTN)

The profit of OptiNose, Inc. (OPTN) on this GURU.Markets chart reflects a trend where -0.03 indicates the level of this metric. OptiNose, Inc. (OPTN) revenues are based on the sale of unique nasopharyngeal sprays; however, financial results depend on critical outsourcing via CROs and CMOs, as well as the modernization of warehouses and the automation of external partners' production lines.

OPTN (OptiNose) Company Net Income history from 07/04/2022 to 05/31/2025

Financial and market metric breakdowns for OptiNose (OPTN)

- price and consensus price forecast:
Stock Quotes OptiNose Corp|OPTN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization OptiNose Corp|OPTN - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share OptiNose|OPTN - Company Book Value|Market-to-Book Ratio optinose.com|OPTN - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital OptiNose, Inc.|OPTN - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital OptiNose Inc|OPTN - Company Aggregate Debts|Debts to Book Value OptiNose Corp|OPTN - Company Long-Term Debt|Company Short-Term Loans and Borrowings OptiNose|Immediate Liquidity optinose.com
- net income and valuation multiples indicators:
OPTN - Company Net Income
Fundamental valuation:OPTN OptiNose Corp
Flagship merchandise of OptiNose Inc

This indicator tracks net margins, allowing investors to perform a real-time assessment of operational expense management efficiency and capital buffers. The company's profit dynamics reflect the ability of OptiNose, Inc. (OPTN) to monetize its patent advantages within the XHANCE system, confirming the company's market resilience amid stringent FDA regulatory oversight.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Company Net Income Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Company Net Income|SCPH - Company Net Income|Profit After Tax TECX|TNXP (Tonix Pharmaceuticals) - Net Income|SXTC: Profit After Payment of Taxes|EPRX (Eupraxia Pharmaceuticals, Inc.) - Net Profit|BioHarvest Sciences, Inc. (BHST) - Net Financial Result|Company Net Income Invizyne Technologies, Inc. (EXOZ)|oramed.com - Company Profit|Company Net Income Entera Bio ENTX|ipatherapeutics.com (HYFT) - Company Net Income|ABVC - Company Net Income|Net Financial Result Cumberland Pharmaceuticals Inc CPIX|QNTM: Net Profit|Company Net Income FibroGen Corporation (FGEN)|Net Income TELO|RANI: Final Profit|Net Profit SNYR|Net Financial Result rallybio.com|Company Net Income Lexaria Bioscience Corp. LEXX|PULM: Company Profit|Pheton - Net Profit|Aptorum Group Limited (APM) - Net Income|LYRA (Lyra Therapeutics) - Net Income|IBO - Net Financial Result|Company Net Income TNF Pharmaceuticals Inc.|Company Net Income cbdMD Corp YCBD|Company Net Income PainReform Ltd. (PRFX)|CYTO: Profit After Tax|Lipella Pharmaceuticals, Inc. - Net Income|Profit After Payment of Taxes PIRS (Pieris Pharmaceuticals Inc)|PROC - Company Net Income|PTPI (Petros Pharma) - Company Profit|Qilian International (QLI) - Company Net Income|Profit After Tax SLRN (acelyrin.com)|TFFP (TFF Pharmaceuticals, Inc.) - Net Profit